Konkurencja i konsument · 02/01/1996
Johnson & Johnson Reaches Consent Agreement to Address Antitrust Concerns Over Cordis Acquisition
Johnson & Johnson has agreed to divest its Cordis Neuroscience Business to settle allegations of violating federal law, reducing competition in the market for neurological shunts. The company will be required to sell the business to address concerns about market dominance.